Maxwell Life Science Ltd Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs |

BSE Share Price
Not Listed

Maxwell Life Science Ltd Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs |

DeciZen - make an informed investing decision on Maxwell Life Science

Based on:

DeciZen not available for IPO

10 Year X-Ray of Maxwell Life Science:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24TTM
ROCE % 10.1%13.6%34.3%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 28.546.681.70
Sales YoY Gr.-63.2%75.5%-
Adj EPS -0.30.230
YoY Gr.-NA1304.8%-
BVPS (₹) 44.57.50
Adj Net
Profit
-0.50.34.6NAN
Cash Flow from Ops. 20.90.7-
Debt/CF from Ops. 7.417.629.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA75.5%
Adj EPS NANANA1304.8%
BVPSNANANA67.1%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24TTM
Return on
Equity %
-7.85.149.40
Op. Profit
Mgn %
8.96.712.1NAN
Net Profit
Mgn %
-1.70.75.6NAN
Debt to
Equity
2.42.31.7-
Working Cap
Days
03252320
Cash Conv.
Cycle
091770

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Maxwell Life Science Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray of Maxwell Life Science:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Maxwell Life Science - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Maxwell Life Science

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Sales28.5346.5781.72
Operating Expenses 2643.4671.86
Manufacturing Costs2.122.202.30
Material Costs20.3637.2164.36
Employee Cost 2.632.713.12
Other Costs 0.891.332.07
Operating Profit 2.533.119.86
Operating Profit Margin (%) 8.9%6.7%12.1%
Other Income 0.650.560.14
Interest 1.622.023.04
Depreciation 0.800.670.68
Exceptional Items -0.2300
Profit Before Tax 0.540.986.28
Tax 0.730.261.61
Profit After Tax -0.200.724.67
PAT Margin (%) -0.7%1.5%5.7%
Adjusted EPS (₹)-0.10.53.0
Dividend Payout Ratio (%)0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 6.246.9611.63
Share Capital 3.893.893.89
Reserves 2.353.077.74
Minority Interest000
Debt14.8015.5216.95
Long Term Debt1.171.963.02
Short Term Debt13.6413.5713.94
Trade Payables14.2330.0322.28
Others Liabilities 3.383.779.91
Total Liabilities 38.6656.2860.76

Fixed Assets

Gross Block14.6815.0716.79
Accumulated Depreciation8.599.259.94
Net Fixed Assets 6.105.826.86
CWIP 000
Investments 0.010.050.05
Inventories11.2418.2219.14
Trade Receivables16.4025.3230.35
Cash Equivalents 0.010.010.16
Others Assets 4.906.864.21
Total Assets 38.6656.2860.76

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Cash Flow From Operating Activity 2.020.900.68
PBT 0.540.986.28
Adjustment 1.971.863.12
Changes in Working Capital -0.27-1.69-7.1
Tax Paid -0.22-0.25-1.61
Cash Flow From Investing Activity -0.530.07-2.20
Capex -0.66-0.39-1.72
Net Investments 0-0.040
Others 0.130.50-0.48
Cash Flow From Financing Activity -1.52-0.971.66
Net Proceeds from Shares 000
Net Proceeds from Borrowing 0.120.791.06
Interest Paid -1.62-1.74-2.53
Dividend Paid 000
Others -0.03-0.023.12
Net Cash Flow -0.0300.14

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24
Ratios
ROE (%)-3.1610.8650.24
ROCE (%)10.1213.6434.29
Asset Turnover Ratio0.740.981.4
PAT to CFO Conversion(x)N/A1.250.15
Working Capital Days
Receivable Days210164124
Inventory Days14411583
Payable Days255217148

Maxwell Life Science Ltd Stock News

Maxwell Life Science Ltd FAQs

The current trading price of Maxwell Life Science on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Maxwell Life Science stood at ₹0.00.
The latest P/E ratio of Maxwell Life Science as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Maxwell Life Science as of 31-Dec-1969 is 0.00.
The 52-week high of Maxwell Life Science is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Maxwell Life Science is ₹0.00 ( Cr.) .

About Maxwell Life Science Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×